Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease
Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease
复制标题
DOI：
10.1542/peds.2004-0956
复制
发表时间：
2005-03-01
期刊：
影响因子：
8
通讯作者：
Mettelman, BB
中科院分区：
文献类型：
--
作者：
Gross, SJ;Anbar, RD;Mettelman, BB
Objective. Postnatal dexamethasone treatment of ventilator-dependent preterm infants results in rapid improvement in lung function and reduction in chronic lung disease. However, limited data are available on long-term outcomes after such therapy. We studied growth, neurodevelopmental, and pulmonary outcomes at adolescence in children who had participated in a double-blind, placebo-controlled trial of dexamethasone beginning at 2 weeks of age for the prevention of chronic lung disease.Methods. Thirty-six infants (birth weight
